Skip to main content

Podcasts

Podcasts
06/29/2023
On episode 6 of Oncology Innovations, host Gordon Kuntz sits down with Aimee Ginsburg, PharmD, McKesson Value Pathways, to discuss the value of clinical pathways in a world of rapidly advancing scientific data, and how decision support tools...
On episode 6 of Oncology Innovations, host Gordon Kuntz sits down with Aimee Ginsburg, PharmD, McKesson Value Pathways, to discuss the value of clinical pathways in a world of rapidly advancing scientific data, and how decision support tools...
On episode 6 of Oncology...
06/29/2023
Journal of Clinical Pathways
Podcasts
12/05/2022
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes,...
12/05/2022
Journal of Clinical Pathways
Dan Rhodes, PhD
Podcasts
10/31/2022
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes,...
10/31/2022
Journal of Clinical Pathways
Podcasts
09/08/2022
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discusses the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discusses the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD,...
09/08/2022
Journal of Clinical Pathways
Ira Klein, MD, MBD
Oncology Innovations
08/17/2022
Gordon Kuntz sits down with Ira Klein, MD, MBA, to discuss the need for industry standards in next-generation sequencing and comprehensive genomic profiling and how the lack of standards is impacting patients, providers, and payers.
Gordon Kuntz sits down with Ira Klein, MD, MBA, to discuss the need for industry standards in next-generation sequencing and comprehensive genomic profiling and how the lack of standards is impacting patients, providers, and payers.
Gordon Kuntz sits down with Ira...
08/17/2022
Journal of Clinical Pathways
Carole Tremonti, RN, MBA
Oncology Innovations
08/01/2022
Gordon Kuntz sits down with Carole Tremonti, RN, MBA, of Project Ronin to discuss clinical decision support and artificial intelligence and their role in cancer care.
Gordon Kuntz sits down with Carole Tremonti, RN, MBA, of Project Ronin to discuss clinical decision support and artificial intelligence and their role in cancer care.
Gordon Kuntz sits down with...
08/01/2022
Journal of Clinical Pathways
Bo Gamble, Community Oncology Alliance
Oncology Innovations
05/23/2022
Gordon Kuntz sits down with Bo Gamble of the Community Oncology Alliance to discuss the ASCO-COA Oncology Medical Home Model, which established core elements needed to deliver equitable, high-quality cancer care.
Gordon Kuntz sits down with Bo Gamble of the Community Oncology Alliance to discuss the ASCO-COA Oncology Medical Home Model, which established core elements needed to deliver equitable, high-quality cancer care.
Gordon Kuntz sits down with Bo...
05/23/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Adam Feuerstein, national biotech columnist, STAT, provides a look into the complexity of reporting on biotech and health care advancements, the shift in STAT's editorial focus to COVID-19 coverage from a science and biotech perspective, and...
Adam Feuerstein, national biotech columnist, STAT, provides a look into the complexity of reporting on biotech and health care advancements, the shift in STAT's editorial focus to COVID-19 coverage from a science and biotech perspective, and...
Adam Feuerstein, national...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Michael Sinha, MD, JD, MPH, dissects the legality of international and domestic travel bans from a health policy perspective, the nuances of state-level authority to enforce a lockdown, and more.
Michael Sinha, MD, JD, MPH, dissects the legality of international and domestic travel bans from a health policy perspective, the nuances of state-level authority to enforce a lockdown, and more.
Michael Sinha, MD, JD, MPH,...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Seth Trueger, MD, MPH, FACEP, shares the steps taken in an emergency room setting to prepare for an influx of patients, screening processes for patient a
Seth Trueger, MD, MPH, FACEP, shares the steps taken in an emergency room setting to prepare for an influx of patients, screening processes for patient a
Seth Trueger, MD, MPH, FACEP,...
05/03/2022
Journal of Clinical Pathways